JP2019512018A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019512018A5 JP2019512018A5 JP2018560436A JP2018560436A JP2019512018A5 JP 2019512018 A5 JP2019512018 A5 JP 2019512018A5 JP 2018560436 A JP2018560436 A JP 2018560436A JP 2018560436 A JP2018560436 A JP 2018560436A JP 2019512018 A5 JP2019512018 A5 JP 2019512018A5
- Authority
- JP
- Japan
- Prior art keywords
- hom
- composition
- tissue sample
- expression
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022143467A JP7635939B2 (ja) | 2016-02-04 | 2022-09-09 | 炎症性障害の治療及び診断 |
| JP2024153550A JP2024170560A (ja) | 2016-02-04 | 2024-09-06 | 炎症性障害の治療及び診断 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662291271P | 2016-02-04 | 2016-02-04 | |
| US62/291,271 | 2016-02-04 | ||
| PCT/US2017/015775 WO2017136322A1 (en) | 2016-02-04 | 2017-01-31 | Treatment and diagnosis of inflammatory disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022143467A Division JP7635939B2 (ja) | 2016-02-04 | 2022-09-09 | 炎症性障害の治療及び診断 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019512018A JP2019512018A (ja) | 2019-05-09 |
| JP2019512018A5 true JP2019512018A5 (cg-RX-API-DMAC7.html) | 2020-03-12 |
Family
ID=59499992
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018560436A Pending JP2019512018A (ja) | 2016-02-04 | 2017-01-31 | 炎症性障害の治療及び診断 |
| JP2022143467A Active JP7635939B2 (ja) | 2016-02-04 | 2022-09-09 | 炎症性障害の治療及び診断 |
| JP2024153550A Pending JP2024170560A (ja) | 2016-02-04 | 2024-09-06 | 炎症性障害の治療及び診断 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022143467A Active JP7635939B2 (ja) | 2016-02-04 | 2022-09-09 | 炎症性障害の治療及び診断 |
| JP2024153550A Pending JP2024170560A (ja) | 2016-02-04 | 2024-09-06 | 炎症性障害の治療及び診断 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11268095B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3411479A4 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2019512018A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20180109985A (cg-RX-API-DMAC7.html) |
| CN (1) | CN108779461A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2017213744B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3013898A1 (cg-RX-API-DMAC7.html) |
| CL (3) | CL2018002097A1 (cg-RX-API-DMAC7.html) |
| IL (2) | IL260987B2 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2018009542A (cg-RX-API-DMAC7.html) |
| MY (2) | MY194135A (cg-RX-API-DMAC7.html) |
| SG (2) | SG10201913129QA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017136322A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL260987B2 (en) | 2016-02-04 | 2024-09-01 | Zhenglun Zhu | Treatment and diagnosis of inflammatory disorders |
| KR20220011123A (ko) | 2019-04-11 | 2022-01-27 | 엔클리어 테라피스, 인크. | 뇌척수액 개선 방법 및 이를 위한 디바이스 및 시스템 |
| CN111528842B (zh) * | 2020-05-26 | 2023-01-03 | 复嶂环洲生物科技(上海)有限公司 | 基于生理和行为指标的帕金森病症状定量化评估方法 |
| JP2023543868A (ja) | 2020-09-29 | 2023-10-18 | エンクリアー セラピーズ， インク． | くも膜下液管理方法およびシステム |
| AU2022297513A1 (en) * | 2021-06-23 | 2024-01-18 | Enclear Therapies, Inc. | Method of regulating gene expression |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2709309B1 (fr) | 1993-08-25 | 1995-11-10 | Centre Nat Rech Scient | Compositions cellulaires, préparation et utilisations thérapeutiques. |
| US5583153A (en) | 1994-10-06 | 1996-12-10 | Regents Of The University Of California | Use of taxol in the treatment of rheumatoid arthritis |
| US20030035790A1 (en) | 1999-01-15 | 2003-02-20 | Shu-Hsia Chen | Combination therapy for the prevention or treatment of cancer, inflammatory disorders or infectious diseases in a subject |
| EP1222933A1 (en) | 2001-01-15 | 2002-07-17 | Academisch Ziekenhuis Leiden h.o.d.n., Leids Universitair Medisch Centrum | Generation and/or reduction of new lung tissue in an affected lung, by modulation of the Wnt-pathway |
| US20040142325A1 (en) | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| KR20050115231A (ko) | 2003-02-10 | 2005-12-07 | 내셔날 인스티튜트 오브 어드밴스드 인더스트리얼 사이언스 앤드 테크놀로지 | 포유동물 세포의 조절 |
| EP1712563A4 (en) | 2004-01-27 | 2008-05-28 | Medical & Biol Lab Co Ltd | METHOD FOR ISOLATING MONOCYTES |
| WO2006086345A2 (en) | 2005-02-07 | 2006-08-17 | The Trustees Of Columbia University In The City Of New York | Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity |
| WO2007051077A2 (en) | 2005-10-28 | 2007-05-03 | The Regents Of The University Of California | Methods and compounds for lymphoma cell detection and isolation |
| WO2007078599A2 (en) | 2005-12-16 | 2007-07-12 | The Board Of Trustees Of The Leland Stanford Junior University | Functional arrays for high throughput characterization of gene expression regulatory elements |
| US20070161031A1 (en) | 2005-12-16 | 2007-07-12 | The Board Of Trustees Of The Leland Stanford Junior University | Functional arrays for high throughput characterization of gene expression regulatory elements |
| EP2612675A1 (en) * | 2006-02-22 | 2013-07-10 | Zhenglun Zhu | Treatment of development-related disorders |
| HUE042736T2 (hu) | 2009-07-15 | 2019-07-29 | Zhenglun Zhu | Gyulladásos vagy autoimmun rendellenességek kezelésének irányítása HOM-1 kifejezés alkalmazásával |
| CN103415615B (zh) * | 2010-11-24 | 2015-11-25 | 高红 | 扩增造血干细胞 |
| WO2012170979A1 (en) * | 2011-06-10 | 2012-12-13 | Zhenglun Zhu | Human homeobox gene ventx and macrophage terminal differentiation and activation, compositions and methods thereof |
| EP2961405A4 (en) | 2012-12-14 | 2017-03-29 | The Brigham and Women's Hospital, Inc. | Methods and assays relating to macrophage differentiation |
| JP6559117B2 (ja) * | 2013-04-10 | 2019-08-14 | ツェンルン チュー | ヒト樹状細胞の分化および成熟を調節するホメオボックス転写因子ＶｅｎｔＸ |
| US9428748B2 (en) * | 2013-06-17 | 2016-08-30 | Hong Gao | Method of expanding hematopoietic stem cells |
| SG10201913151TA (en) | 2015-09-09 | 2020-03-30 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Genetic engineering of macrophages for immunotherapy |
| EP3973968A3 (en) | 2015-11-11 | 2022-06-08 | Zhenglun Zhu | Method of modifying macrophage differentiation and immunity |
| IL260987B2 (en) | 2016-02-04 | 2024-09-01 | Zhenglun Zhu | Treatment and diagnosis of inflammatory disorders |
| WO2018183447A1 (en) | 2017-03-28 | 2018-10-04 | Zhenglun Zhu | Methods of treating neoplastic diseases |
-
2017
- 2017-01-31 IL IL260987A patent/IL260987B2/en unknown
- 2017-01-31 US US16/075,479 patent/US11268095B2/en active Active
- 2017-01-31 WO PCT/US2017/015775 patent/WO2017136322A1/en not_active Ceased
- 2017-01-31 MX MX2018009542A patent/MX2018009542A/es unknown
- 2017-01-31 CN CN201780016917.2A patent/CN108779461A/zh active Pending
- 2017-01-31 KR KR1020187025087A patent/KR20180109985A/ko not_active Ceased
- 2017-01-31 JP JP2018560436A patent/JP2019512018A/ja active Pending
- 2017-01-31 MY MYPI2018702738A patent/MY194135A/en unknown
- 2017-01-31 IL IL311968A patent/IL311968B1/en unknown
- 2017-01-31 SG SG10201913129QA patent/SG10201913129QA/en unknown
- 2017-01-31 CA CA3013898A patent/CA3013898A1/en active Pending
- 2017-01-31 AU AU2017213744A patent/AU2017213744B2/en active Active
- 2017-01-31 EP EP17748003.5A patent/EP3411479A4/en active Pending
- 2017-01-31 MY MYPI2021007385A patent/MY203831A/en unknown
- 2017-01-31 SG SG11201806636SA patent/SG11201806636SA/en unknown
-
2018
- 2018-08-03 MX MX2022010890A patent/MX2022010890A/es unknown
- 2018-08-03 CL CL2018002097A patent/CL2018002097A1/es unknown
-
2021
- 2021-12-29 CL CL2021003543A patent/CL2021003543A1/es unknown
-
2022
- 2022-02-18 US US17/675,800 patent/US12146138B2/en active Active
- 2022-09-09 JP JP2022143467A patent/JP7635939B2/ja active Active
-
2023
- 2023-09-22 AU AU2023233180A patent/AU2023233180B2/en active Active
- 2023-10-06 CL CL2023003003A patent/CL2023003003A1/es unknown
-
2024
- 2024-09-06 JP JP2024153550A patent/JP2024170560A/ja active Pending
- 2024-10-17 US US18/918,938 patent/US20250188474A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | LncRNA MALAT1/MiR-145 adjusts IL-1β-induced chondrocytes viability and cartilage matrix degradation by regulating ADAMTS5 in human osteoarthritis | |
| Zhang et al. | MicroRNA-155 contributes to preeclampsia by down-regulating CYR61 | |
| US11053314B2 (en) | Methods to eliminate cancer stem cells by targeting CD47 | |
| Witalison et al. | Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer | |
| ES2724549T3 (es) | ARN pequeños derivados de RNY como biomarcadores para trastornos relacionados con la aterosclerosis | |
| Ni et al. | CircSLC7A2 protects against osteoarthritis through inhibition of the miR‐4498/TIMP3 axis | |
| Tsolou et al. | ‘Stemness’ and ‘senescence’related escape pathways are dose dependent in lung cancer cells surviving post irradiation | |
| US20180110837A1 (en) | Methods and assays relating to macrophage differentiation | |
| WO2021231887A1 (en) | Compositions and methods of detection of pre-symptomatic als | |
| Shiba et al. | Differential roles of MMP-9 in early and late stages of dystrophic muscles in a mouse model of Duchenne muscular dystrophy | |
| Yang et al. | Keratin 5-Cre-driven deletion of Ncstn in an acne inversa-like mouse model leads to a markedly increased IL-36a and Sprr2 expression | |
| CN105987999A (zh) | 用于乳腺癌诊断的联合肿瘤标志物及其试剂盒 | |
| TW202402790A (zh) | 減少呼吸系統感染之方法 | |
| RU2020133768A (ru) | Способ лечения астмы или аллергического заболевания | |
| Ma et al. | MMP19 in vascular smooth muscle cells protects against thoracic aortic aneurysm and dissection via the MMP19/Aggrecan/Wnt/β-catenin axis | |
| Huang et al. | ALKBH5-mediated m6A demethylation fuels cutaneous wound re-epithelialization by enhancing PELI2 mRNA stability | |
| CN114901835B (zh) | 包含mir-335的组合物 | |
| Yang et al. | CircITGA7 regulates malignant phenotypes in bladder cancer cells via targeting miR‐330‐3p/KLF10 axis | |
| US12534729B2 (en) | Uses of synthetic lethal partners for treatment of cancer | |
| CN104436195B (zh) | miR-155在制备防治急性肺损伤药物中的用途 | |
| US9234018B2 (en) | Compositions and methods for the treatment of VprBP-related cancers | |
| Balzanelli et al. | The role of SARS-CoV-2 spike protein in long-term damage of tissues and organs, the Underestimated role of retrotransposons and stem cells, a Working hypothesis | |
| Zhang et al. | Biogenesis and function of circRNAs in pulmonary fibrosis | |
| EP2670772B1 (en) | Antagonists of grasp55 for use as a medicament | |
| Tyagi | COVID-19 Sequalae and Formation of Kidney Stone by Decrease in Mitochondrial Sulfur Metabolism Transsulfuration and Hyperuricemia during CKD |